Effects Of Emotional Freedom Technique and Hypermesis Gravidarum (NCT06442813) | Clinical Trial Compass
UnknownNot Applicable
Effects Of Emotional Freedom Technique and Hypermesis Gravidarum
Turkey (Türkiye)74 participantsStarted 2024-06-10
Plain-language summary
The purpose of this clinical study is to determine whether EFT (Emotional Freedom Techniques) is effective in alleviating nausea and vomiting in pregnant women with hyperemesis. Additionally, the study aims to gather information on the safety of EFT application. The primary questions it seeks to answer are:
Does EFT reduce nausea and vomiting in pregnant women with hyperemesis? Is EFT applicable for use in pregnant women with hyperemesis? Researchers will compare the effectiveness of EFT to traditional nursing education on non-pharmacological interventions for preventing nausea and vomiting in pregnant women with hyperemesis.
Participants:
Pre-EFT application survey scale questions will be asked to the pregnant women with hyperemesis.
EFT will be applied once by the researcher to the pregnant women with hyperemesis.
For control, the same survey scale questions will be asked to the same pregnant women two days after the EFT application for post-test purposes.
For control, the same survey scale questions will be asked to the same pregnant women seven days after the EFT application for post-test purposes.
The same procedures will be applied in the same manner to the control group that will receive education.
Who can participate
Age range
20 Years – 40 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pregnant women between 6-14 weeks of pregnancy
* Pregnant women between the ages of 20-40
* Pregnant women with complaints of nausea and vomiting
* Pregnant women who report their discomfort as 5 or above on the vas scale
* Pregnant women who have not been diagnosed with risky pregnancy
* Pregnant women who do not have any psychological disorders
* Pregnant women who voluntarily agreed to participate in the research
Exclusion Criteria:
* Coordination and language problems in the pregnant woman
* Wants to leave the study at any time
* Not wanting to participate in the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pregnancy-Unique Quantification of Emesis and Nausea (PUQE-24)